Delivery Order SPE2DR25D2010-SPE2DR26F4ZER
- Not listed
- The Defense Logistics Agency awarded a $13,817.08 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed price contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,252.23 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure and was finalized on November 4, 2025, with an ultimate completion date of November 5, 2025. The pharmaceutical will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,507.26 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on May 30, 2025, with completion scheduled for June 2, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $6,143.50 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory treatment, with delivery to the company's Conshohocken, Pennsylvania location. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract carries no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a Delivery Order valued at $16,547.64 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder used for chronic obstructive pulmonary disease management. The competitively awarded contract, which was not set aside for any specific business category, is firm fixed price and was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be performed and delivered from...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.34 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This firm fixed price delivery order, issued on August 5, 2025, represents a single transaction under a larger contract vehicle. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $11,705.24 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. Issued on December 11, 2025, with an ultimate completion date of December 12, 2025, this firm fixed price delivery order represents a non-set-aside competitive award. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,609.36 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on August 26, 2025, represents a non-competitive award under the company's existing contract vehicle and is scheduled for completion by August 27, 2025. Performance will be conducted at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $39,375.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, which was competitively awarded without set-aside designation, was issued on September 16, 2025, with an ultimate completion date of September 17, 2025. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZERDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $39,494.93 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively on December 9, 2025, with an ultimate completion date of December 10, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The arrangement supports federal medical procurement for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.5k | 12/8/25 |